Table 4.
Glucose and insulin concentrations at baseline, after 4 weeks, and after 8 weeks of supplementation
| Placebo | OLE | Uncorrected p1 | Uncorrected p2 | |||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 4 weeks | 8 weeks | Baseline | 4 weeks | 8 weeks | |||
| Glucose (mmol/L) | 5.2 ± 0.1 | 5.2 ± 0.1 | 5.2 ± 0.1 | 5.2 ± 0.1 | 5.3 ± 0.1 | 5.3 ± 0.1 | 0.229 | 0.024a |
| Insulin (pmol/L) | 87.7 ± 21.0 | 97.7 ± 23.6 | 92.7 ± 24.8 | 65.1 ± 20.7 | 55.1 ± 23.2 | 62.5 ± 24.5 | 0.155 | 0.467 |
All values are presented as mean ± SEM. Differences between the placebo and OLE were compared with an unstructured linear mixed model with correction for baseline values. p1 and p2 represent the p values for the difference in estimated means after 4 and 8 weeks of intervention, respectively, between placebo and OLE, corrected for baseline differences
OLE olive leaf extract
ap > 0.05 after correction for multiple testing by the false-discovery rate (FDR) of Benjamini–Hochberg (4 tests)